Do Women Have Stronger Immune Systems?

Women generally mount stronger immune responses than men, clearing many infections faster and producing more robust antibody reactions after vaccination. This advantage traces to a combination of genetics and hormones, primarily the extra copy of the X chromosome and the immune-boosting effects of estrogen. But the same heightened responsiveness that helps women fight off pathogens also turns against them in a significant way: women account for a disproportionate share of autoimmune diseases. The full picture is more complex and more interesting than a simple ranking of “stronger” versus “weaker.”

What the X Chromosome Contributes

The X chromosome carries a dense concentration of immune-related genes. Because women have two copies, they carry a built-in genetic redundancy that men, with only one X, lack. In theory, one of a woman’s two X chromosomes is silenced early in development to balance gene expression between the sexes. In practice, roughly 15 to 30 percent of genes on the silenced X escape that shutdown and continue to be expressed from both copies.¹ The result is that many female cells produce higher quantities of certain immune proteins than male cells do.

One of the most consequential escapee genes is TLR7, which encodes a receptor that detects viral RNA inside cells. When immune cells called plasmacytoid dendritic cells express TLR7 from both X chromosomes instead of one, they produce significantly higher levels of type I interferons, the signaling molecules that serve as an early alarm system against viral invasion.² This helps explain why women are generally less susceptible to a range of viral infections.³

The same TLR7 pathway, however, illustrates the cost of a revved-up immune system. When researchers deliberately disrupted X chromosome inactivation in female mice, the reactivation of TLR7 and related genes in immune cells caused the animals to spontaneously develop inflammatory signs of lupus, including autoantibodies targeting the body’s own nucleic acids.⁴ That experiment drew a direct line from the genetics of X inactivation to the lopsided burden of autoimmune disease in women.

Estrogen and Testosterone Pull in Opposite Directions

Sex hormones are the other major lever. Estrogen broadly amplifies immune activity. In B cells, the antibody-producing arm of the adaptive immune system, estrogen receptors bind directly to regulatory regions of the immunoglobulin gene locus, influencing how much antibody a cell can make and how effectively it can switch between antibody types.⁵ Lab experiments have shown that estrogen significantly boosts certain gene transcripts involved in antibody production, providing a direct explanation for why females tend to produce higher antibody levels than males.⁶

Testosterone, by contrast, dials certain immune functions down. Studies across multiple contexts point to testosterone suppressing different parts of the immune system, although the exact molecular mechanisms are still being worked out.⁷ That said, the old framing of testosterone as purely “immunosuppressive” is an oversimplification. Research in a forager-horticultural population found that testosterone’s effects are more selective: men with higher testosterone showed dampened T-cell-driven responses but less impact on B-cell-mediated immunity, suggesting testosterone is better described as immunomodulatory.⁸ It reshapes the immune response rather than simply weakening it.

How These Differences Show Up During Infections

The practical consequence is visible across many infectious diseases. Men are broadly more susceptible to infection with a range of viruses.⁹ Sepsis offers one of the starkest examples. In a large prospective study, men had a substantially higher rate of sepsis hospitalization than women, and were more likely to need intensive care. One-year mortality was also higher in men, and they had longer hospital and ICU stays.¹⁰ This pattern holds consistently across studies: men have higher sepsis incidence and, in many reports, higher mortality.¹¹ Male sex hormones appear to play a role by dampening cell-mediated immune responses that are critical for fighting severe bacterial infections.¹²

Influenza complicates the picture in an interesting way. Before puberty, boys tend to have more severe seasonal flu. After puberty, the pattern flips, and women of reproductive age tend to fare worse.⁹ In controlled human challenge studies, where volunteers are deliberately exposed to flu virus, women actually reported more symptoms and had a longer duration of illness, even though viral shedding was similar between sexes.¹³ This is a case where a stronger inflammatory response may not be a straightforward advantage. In mouse models of H7N9 influenza, female mice developed more severe disease, associated with a more aggressive inflammatory host response.¹⁴ When it comes to influenza, “stronger immunity” can mean more collateral damage to the lungs.

The Autoimmune Trade-Off

The flip side of heightened immune vigilance is a greater tendency to attack the body’s own tissues. Autoimmune diseases like lupus and Sjögren’s syndrome show dramatic sex disparities, with women disproportionately affected.¹⁵ The pattern is broad: the more common an autoimmune disease and the later in life it appears, the more likely it is to predominantly affect women.¹⁶

This is not a side effect or a coincidence. The same mechanisms that give women stronger antiviral and antibacterial responses, the extra X chromosome genes, the estrogen-driven antibody production, the more reactive innate immune cells, are the mechanisms that overshoot into autoimmunity. A woman’s immune system is, in a real sense, operating closer to the edge of self-attack. The TLR7 experiments in mice, where disrupting X inactivation produced lupus-like disease, illustrate this directly: the line between excellent pathogen detection and autoimmune inflammation is a matter of degree, not of kind.

Women Build Better Vaccine Responses

Women consistently develop higher antibody levels after vaccination than men.¹⁷ This has been documented across a range of vaccines, and it tracks logically with the rest of the picture: if estrogen drives higher antibody production and X-linked genes amplify innate signaling, you would expect vaccination to trigger a bigger response in women. And it does. That enhanced reactivity likely makes women more resistant to the infections those vaccines target.¹⁸

The trade-off, predictably, is that women also experience more adverse reactions after vaccination, from sore arms and fevers to more serious side effects. This has led some researchers to argue that vaccine dosing should be reevaluated by sex. Women might achieve equivalent protection at lower doses, which would reduce side effects without sacrificing efficacy. That possibility is still being explored, but the biological rationale is sound given what we know about the sex-based differences in humoral immunity.¹⁹

An Evolutionary Explanation

Why would evolution produce this asymmetry? One compelling explanation focuses on motherhood. Because mothers can transmit pathogens to their children during pregnancy, birth, and breastfeeding, a mother who clears infections faster protects not just herself but her offspring. Modeling work has shown that even a small amount of vertical (mother-to-child) pathogen transmission is sufficient to favor faster recovery in women over evolutionary time.²⁰

A complementary explanation draws on life history theory. Female mammals tend to maximize reproductive success by surviving long enough to raise offspring through their prolonged dependence period. Males, by contrast, often invest more in competition for mates, which channels resources away from immune maintenance. Across mammalian species, females tend to have higher white blood cell counts, and the size of that sex difference in immunity correlates with the difference in effective breeding lifespan, consistent with the idea that females invest more in long-term survival through immune defense.²¹ These two pressures, protecting offspring from vertically transmitted infections and maximizing lifespan, reinforce each other.

Pregnancy Temporarily Reshapes the Equation

Pregnancy itself creates a paradox for the immune system. A fetus carries half its genetic material from the father, making it immunologically foreign. To avoid rejecting the pregnancy, a woman’s immune system undergoes significant shifts, generally moving away from aggressive cell-mediated responses and toward antibody-mediated immunity.²² The placenta itself has specialized immune properties that affect how the woman responds to certain pathogens.²³

This recalibration has real costs. Pregnant women face increased susceptibility to certain infections, including toxoplasmosis and listeriosis, and more severe illness from influenza and chickenpox.²² The same immune system that is usually “stronger” becomes temporarily more vulnerable in specific ways. Life history theory frames this as a resource allocation problem: reproduction demands so much energy that immune function, normally well-funded in women, gets temporarily deprioritized.²⁴

What Puberty and Aging Tell Us

The sex differences in immunity are not static across a lifetime. They emerge, shift, and eventually narrow. In children, the immune landscape changes substantially around puberty. Longitudinal research in children with asthma found that gene expression in immune cells shifts markedly as girls pass through menarche, with a transition from predominantly innate immune signatures to adaptive immunity signatures.²⁵ This aligns with the observation that many sex-based differences in disease susceptibility, including the flip in influenza severity patterns, track with puberty and the rise of sex hormones.

At the other end of life, immune aging, or immunosenescence, affects both sexes but on different timelines. Aging is the dominant driver of immune decline regardless of sex: naive T cells fall, inflammatory signaling rises, and the system becomes less responsive to new threats.²⁶ But biological and social factors create divergent trajectories, and the female advantage in immune function appears to contribute to women’s greater average longevity.²⁷ After menopause, as estrogen levels drop, some of the sex differences narrow, though they do not disappear entirely because X-linked genetic effects persist regardless of hormone levels.

What Testosterone Therapy Reveals

Some of the most illuminating recent evidence comes from transgender men undergoing testosterone therapy, which provides a kind of natural experiment. A longitudinal study tracking 23 trans men found that testosterone administration directly dampened type I interferon responses in dendritic cells and monocytes, the same responses that are stronger in female immune systems. At the same time, testosterone boosted inflammatory pathways involving tumor necrosis factor and related molecules in monocytes and natural killer cells.²⁸ In effect, testosterone therapy shifted the immune system’s profile away from the antiviral interferon axis and toward a different inflammatory configuration. This study offered some of the clearest evidence yet that sex hormones directly reshape immune function in living humans, not just in cell cultures or mouse models.

Sex Differences in Cancer Immunotherapy

The immune differences between sexes carry implications for cancer treatment, particularly immunotherapy. When therapies aim to suppress an overactive immune response, as checkpoint inhibitors do in melanoma, men tend to see greater benefit than women.²⁹ This may seem counterintuitive until you consider the underlying biology: if women’s immune systems are already more active at baseline, further tweaking the immune response through checkpoint blockade may produce a different balance of benefit and harm. The landscape is also complicated by the fact that certain tumor types show sex-biased molecular features. Male patients with melanoma and bladder cancer tend to have higher tumor mutation burdens, which is one predictor of response to immunotherapy.³⁰ So the sex difference in treatment outcomes is not purely about immune strength; it is entangled with differences in the tumors themselves.

Brain Immunity Differs Too

The sex-based immune asymmetry extends into the brain. Microglia, the resident immune cells of the central nervous system, differ between sexes in number, gene expression, and behavior. These differences exist even in healthy brains and shift over the lifespan.³¹ In rodent studies, these structural and functional differences have been convincingly demonstrated.³² Sex is a recognized risk factor in several neuroinflammatory and neurodegenerative diseases, and microglia respond to chronic stress in sex-specific and brain-region-specific ways.³³ This area of research is relatively young, and the clinical implications are still being mapped, but it reinforces the point that sex shapes immunity at every level, not just in the bloodstream.

The Research Gap That Still Matters

For decades, biomedical research defaulted to studying male animals and enrolling male-dominated study populations, leaving female-specific immune biology understudied. In 2016, the U.S. National Institutes of Health implemented a policy requiring researchers to account for sex as a biological variable in study design and analysis.³⁴ A recent evaluation of how well the policy is working found that while about 61 percent of funded studies now include both sexes, fewer than half actually analyze their data by sex. Studies with women as lead investigators were significantly more likely to perform sex-based analyses.³⁵

Certain fields remain especially sparse. Research on sex differences in mucosal immunity, the defenses that line the gut, bladder, and respiratory tract, is still in early stages. There is little knowledge of how biological sex affects the mucus barrier during either normal conditions or infection, and fundamental research on bladder mucus, despite the well-known sex differences in urinary tract infections, is almost nonexistent.³⁶ Sex hormones also influence the gut microbiome, with hormonal fluctuations during the menstrual cycle shaping gut barrier function and immune responses.³⁷ These interactions likely contribute to sex differences in conditions ranging from irritable bowel syndrome to autoimmune gut diseases, but the data is thin enough that researchers are still establishing baselines rather than drawing firm conclusions. The gaps are as telling as the findings: they highlight how much of immunology was built on the assumption that sex did not matter, and how much catch-up work remains.